* Onxeo S.A.: combination of AsiDNA and PARP inhibitors
demonstrates synergistic effect, bypasses genetic restriction
Source text for Eikon:
The post BRIEF-Onxeo S.A. says combination of AsiDNA and PARP inhibitors demonstrates synergistic effect appeared first on NASDAQ.